Human Immunodeficiency Virus Type 1 Particles Pseudotyped with Envelope Proteins That Fuse at Low PH No Longer Require Nef for Optimal Infectivity

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2001 Mar 27

PMID 11264394

Citations 61

Authors

N Chazal

G Singer

C Aiken

M L Hammarskjold

D Rekosh

Affiliations

Soon will be listed here.

Abstract

We have investigated the effects of Nef on infectivity in the context of various viral envelope proteins. These experiments were performed with a minimal vector system where Nef is the only accessory protein present. Our results support the hypothesis that the route of entry influences the ability of Nef to enhance human immunodeficiency virus (HIV) infectivity. We show that HIV particles pseudotyped with Ebola virus glycoprotein or vesicular stomatitis virus glycoprotein (VSV-G), which fuse at low pH, do not require Nef for optimal infectivity. In contrast, Nef significantly enhances the infectivity of virus particles that contain envelope proteins that fuse at neutral pH (CCR5-dependent HIV Env, CXCR4-dependent HIV Env, or amphotropic murine leukemia virus Env). In addition, our results demonstrate that virus particles containing mixed CXCR4-dependent HIV and VSV-G envelope proteins show a conditional requirement for Nef for optimal infectivity, depending on which protein is allowed to facilitate entry.

Citing Articles

Fusogenic structural changes in arenavirus glycoproteins are associated with viroporin activity.

Zhang Y, York J, Brindley M, Nunberg J, Melikyan G PLoS Pathog. 2023; 19(7):e1011217.

PMID: 37494374 PMC: 10406333. DOI: 10.1371/journal.ppat.1011217.

The host cytoskeleton: a key regulator of early HIV-1 infection.

Stephens C, Naghavi M FEBS J. 2022; 291(9):1835-1848.

PMID: 36527282 PMC: 10272291. DOI: 10.1111/febs.16706.

Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions.

Liu S, Hossinger A, Heumuller S, Hornberger A, Buravlova O, Konstantoulea K Nat Commun. 2021; 12(1):5739.

PMID: 34667166 PMC: 8526834. DOI: 10.1038/s41467-021-25855-2.

Mechanisms of Immune Evasion by Ebola Virus.

Bhattacharyya S Adv Exp Med Biol. 2021; 1313:15-22.

PMID: 34661889 DOI: 10.1007/978-3-030-67452-6_2.

HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection.

Naghavi M Retrovirology. 2021; 18(1):19.

PMID: 34229718 PMC: 8259435. DOI: 10.1186/s12977-021-00563-3.

References

Chan S, Speck R, Ma M, Goldsmith M . Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol. 2000; 74(10):4933-7. PMC: 112022. DOI: 10.1128/jvi.74.10.4933-4937.2000. View

Kotov A, Zhou J, Flicker P, Aiken C . Association of Nef with the human immunodeficiency virus type 1 core. J Virol. 1999; 73(10):8824-30. PMC: 112905. DOI: 10.1128/JVI.73.10.8824-8830.1999. View

Matlin K, Reggio H, Helenius A, Simons K . Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol. 1982; 156(3):609-31. DOI: 10.1016/0022-2836(82)90269-8. View

Yamada S, Ohnishi S . Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes. Biochemistry. 1986; 25(12):3703-8. DOI: 10.1021/bi00360a034. View

Gerard R, Gluzman Y . New host cell system for regulated simian virus 40 DNA replication. Mol Cell Biol. 1985; 5(11):3231-40. PMC: 369139. DOI: 10.1128/mcb.5.11.3231-3240.1985. View

Stein B, Gowda S, Lifson J, Penhallow R, Bensch K, Engleman E . pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 1987; 49(5):659-68. DOI: 10.1016/0092-8674(87)90542-3. View

Pauza C, Price T . Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol. 1988; 107(3):959-68. PMC: 2115279. DOI: 10.1083/jcb.107.3.959. View

Bowman E, Siebers A, Altendorf K . Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A. 1988; 85(21):7972-6. PMC: 282335. DOI: 10.1073/pnas.85.21.7972. View

Camerini D, Seed B . A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell. 1990; 60(5):747-54. DOI: 10.1016/0092-8674(90)90089-w. View

10.

Lewis N, Williams J, Rekosh D, Hammarskjold M . Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins. J Virol. 1990; 64(4):1690-7. PMC: 249306. DOI: 10.1128/JVI.64.4.1690-1697.1990. View

11.

McClure M, Sommerfelt M, Marsh M, Weiss R . The pH independence of mammalian retrovirus infection. J Gen Virol. 1990; 71 ( Pt 4):767-73. DOI: 10.1099/0022-1317-71-4-767. View

12.

Grewe C, Beck A, Gelderblom H . HIV: early virus-cell interactions. J Acquir Immune Defic Syndr (1988). 1990; 3(10):965-74. View

13.

Umata T, Moriyama Y, Futai M, Mekada E . The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase. J Biol Chem. 1990; 265(35):21940-5. View

14.

Landau N, Page K, Littman D . Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol. 1991; 65(1):162-9. PMC: 240501. DOI: 10.1128/JVI.65.1.162-169.1991. View

15.

Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y . Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991; 266(26):17707-12. View

16.

Kimpton J, Emerman M . Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol. 1992; 66(4):2232-9. PMC: 289016. DOI: 10.1128/JVI.66.4.2232-2239.1992. View

17.

Rizvi T, Panganiban A . Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J Virol. 1993; 67(5):2681-8. PMC: 237590. DOI: 10.1128/JVI.67.5.2681-2688.1993. View

18.

Miller M, Warmerdam M, Gaston I, Greene W, Feinberg M . The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med. 1994; 179(1):101-13. PMC: 2191317. DOI: 10.1084/jem.179.1.101. View

19.

Chowers M, Spina C, Kwoh T, Fitch N, Richman D, Guatelli J . Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol. 1994; 68(5):2906-14. PMC: 236779. DOI: 10.1128/JVI.68.5.2906-2914.1994. View

20.

Miller M, Feinberg M, Greene W . The HIV-1 nef gene acts as a positive viral infectivity factor. Trends Microbiol. 1994; 2(8):294-8. DOI: 10.1016/0966-842x(94)90007-8. View